Page 1 - hypertension_newsletter9

REFLECTIONS
Hypertension Global Newsletter #9 2025
TABLE OF CONTENTS
KEY ARTICLES
GUIDELINES
European guidelines for hypertension in 2024: A
comparison of key recommendations for clinical
practice. Lauder L, et al. Nat Rev Cardio. 2025
Sep;22(9):675-688.
Development of the European Society of
Hypertension guidelines for the management
of arterial hypertension: Comparison of the
helpfulness of ESH 2013, 2018, and 2023
guidelines. Koller A, et al. J Hypertens. 2025
Feb;43(5):852-858.
TREATMENT
Lorundrostat in participants with uncontrolled
hypertension and treatment-resistant
hypertension: The launch-HTN randomized
clinical trial. Saxena M, et al. JAMA. 2025
Jun;334(5):409-418.
Long-term event rates, risk factors, and treatment
pattern in 1.4 million individuals qualifying for
dual blood pressure lowering therapy. Coca A, et
al. J Hypertens. 2025 Jun;43(6):993-1002.
BLOOD PRESSURE MONITORING
Cuffless blood pressure measurement: Where
do we actually stand? Mukkamala R, et al.
Hypertension. 2025 Jun;82(6):957-970.
Effect of telemonitoring and home blood pressure
monitoring on blood pressure reduction in
hypertensive adults: A network meta-analysis.
Grover S, et al. J Hypertens. 2025 Jul;43(7):1091-
1098.
ADDITIONAL ARTICLES OF INTEREST
CONFERENCE CORNER
Highlighted abstracts of interest from the ESC
2025 conference
Hypertension
Welcome back to the REFLECTIONS Hypertension
Global Newsletter series, which draws on the expertise of
international physicians to summarise the latest clinical and
real-world evidence in the field of hypertension and reflect
Hypertension
on the clinical impact of these new data on the management
of patients with hypertension. Since our last newsletter, there
have been very many new and interesting publications in
the active field of clinical research in hypertension; therefore,
the Scientific Planning Committee was tasked with choosing
from an extensive list of articles from high-quality scientific
journals. To make this last selection, we privileged novel
findings rather than confirmation papers, and articles
with a direct application to antihypertensive treatment in
routine clinical practice. In this newsletter, we will focus on
1) the latest evolution and comparison of major European
hypertension guidelines, 2) the efficacy and safety of novel
pharmacological approaches, particularly those targeting
resistant hypertension, and 3) recent evidence concerning
the effectiveness and validity of cutting-edge blood pressure
monitoring technologies. As with previous newsletters, we
invite you to interact with this through links to commentary
videos from authors of the publications and short video
clinical perspectives from our Scientific Planning Committee
(SPC), and delve into the articles through hyperlinks for in-
depth study.
Prof. Laurent (Chair)
SCIENTIFIC PLANNING COMMITTEE
Prof. Stéphane Laurent Prof. Diego Araiza
(France) (Mexico)
Dr. Om Narayan Prof. Zainab Raissuni
(Australia) (Morocco)
Dr. Juan Camilo Dr. Michal Fikrle
Pedreros Guerra (Czech Republic)
(Colombia)